Condition: Convulsive Status EPILEPTICUS · Sponsor: Sohag University
The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.
This description comes directly from the study's public registry record.
Elsayed Abdelkreem · 1114232126 · d.elsayedmohammed@med.sohag.edu.eg
Always discuss trial participation with your own doctor first.
| Department of Pediatrics at Sohag University Hospital | Sohag, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07095842